Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Shire Rises As US FDA Approves Takhzyro Drug

Fri, 24th Aug 2018 10:39

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------Shire, up 2.6%. The Irish pharmaceutical company said the US Food & Drug Administration has approved its Takhzyro drug to treat a rare genetic disease. The disease, hereditary angioedema, causes attacks of swelling in different parts of the body and can be life-threatening. Approval from the FDA follows a phase III study of 125 patients in which Takhzyro reduced monthly attacks by, on average, 87% in patients when compared with a placebo. Antofagasta, up 2.0%. RBC Capital upgraded the Chilean copper miner to Outperform from Sector Perform. ----------FTSE 100 - LOSERS----------Berkeley Group, down 2.3%, Barratt Developments, down 1.9%, Persimmon, down 1.7%, Taylor Wimpey, down 1.2%. The housebuilders were lower amid a decline in UK mortgage approvals in July. The number of mortgages approved in July fell to 39,584 from 40,330 in June. Economists had forecast approvals to rise to 40,650, data from UK Finance showed. "Housebuilders have taken a knock as a double whammy of lower new approved mortgages and a five-month low in mortgage lending weighed on the sector," IG Group analyst Chris Beauchamp said. Midcap peers McCarthy & Stone, Bovis Homes and Bellway were down 2.1%, 1.4% and 1.2%, respectively. ----------FTSE 250 - WINNERS----------Ted Baker, up 2.0%. Peel Hunt raised the high street fashion retailer to Add from Hold. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Henry Boot, up 4.5%. The construction company said interim profit and revenue both rose in an "impressive" first half performance. For the six months to June, Henry Boot's pretax profit was up 16% to GBP26.2 million, while revenue rose slightly to GBP196.2 million from GBP195.4 million a year prior. Its net asset value per share increased by 18% to 217 pence. Henry Boot is paying an interim dividend to shareholders of 3.20p, from 2.80p a year prior. The company said it has seen "consistent" levels of demand across all of its businesses in the first half of 2018, particularly in housing development land. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Bahamas Petroleum, down 63%. The oil and gas explorer said its exclusivity agreement with a major international oil company will terminate at the end of the month. The unnamed international company has notified Bahamas that it will not be extending the agreement, which has been in place since the start of May, past next Friday and will cease exclusivity payments. Bahamas said it has recommenced broader asset-based discussions with third parties. These will continue alongside the ongoing non asset-based discussions which surround the funding of its first exploration well.----------
More News
14 Sep 2018 09:15

Shire gains as takeover approved by China

(Sharecast News) - Japan's Takeda Pharmaceutical has received regulatory approval from China for its $62bn takeover of London-listed Shire.

Read more
13 Sep 2018 10:56

Takada eyeing potential Shire asset sales to pay down debt

(Sharecast News) - Takeda Pharmaceutical may try and sell Shire's dry-eye drug once it completes the $62bn takeover purchase of the UK-listed biotech, according to a report on Thursday.

Read more
13 Sep 2018 08:25

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 (Reuters) - Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks a

Read more
12 Sep 2018 16:12

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Sept 12 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the —

Read more
12 Sep 2018 07:22

Shire gets EC marketing authorisation for 'VEYVONDI' treatment

(Sharecast News) - Rare diseases specialist Shire announced on Wednesday that the European Commission has granted marketing authorisation for 'VEYVONDI', for the treatment of bleeding events and the treatment and prevention of surgical bleeding in adults with von Willebrand disease, when desmopressin treatment alone is ineffective or not indicated.

Read more
10 Sep 2018 16:08

Two Shire Subsidiaries Receive Majority Early Offers For Senior Notes

LONDON (Alliance News) - Biotechnology company Shire PLC on Monday said two of its subsidiaries, Baxalta Inc and Shire Acquisitions Investments Ireland DAC, had received early offers for a of the

Read more
7 Sep 2018 09:33

BROKER RATINGS SUMMARY: Goldman Cuts Burberry; Redburn Cuts HSBC

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS GROUP TO BUY -

Read more
6 Sep 2018 11:20

European Shares Reverse Early Losses On Improving Sentiment

BRUSSELS/FRANKFURT/PARIS (Alliance News) - European stocks were marginally higher on Thursday after having fallen to a five-month low earlier in the day.Sentiment improved somewhat after US

Read more
6 Sep 2018 10:54

TOP NEWS: Shire Buys Swiss Plasma Collection Firm Sanaplasma

LONDON (Alliance News) - Shire PLC said Thursday it has bought Swiss source plasma collection company sanaplasma AG for an undisclosed sum.The FTSE 100 pharmaceutical giant said that the is

Read more
6 Sep 2018 10:52

Shire buys Swiss plasma firm sanaplasma for undisclosed sum

(Sharecast News) - Pharmaceuticals giant Shire on Thursday said it had bought Switzerland's sanaplasma AG for an undisclosed sum.

Read more
6 Sep 2018 07:48

UPDATE 1-UK Stocks-Factors to watch on Sept. 6

Sept 6 (Reuters) - Britain's FTSE 100 futures were down 0.1 percent ahead of the cash market open on Thursday. * DIXONS CARPHONE: Dixons Carphone, the troubled British electricals and a

Read more
31 Aug 2018 10:16

Shire Completes USD2.4 Billion Oncology Franchise Sale To Servier

LONDON (Alliance News) - Irish biotechnology giant Shire PLC said Friday it has completed the sale of its oncology franchise to Servier SAS.The FTSE 100-listed company sold its franchise, a

Read more
31 Aug 2018 09:07

Shire completes $2.4bn oncology sale to Servier

(Sharecast News) - Shire has completed the sale of its oncology franchise to Servier for $2.4bn, it announced on Friday.

Read more
24 Aug 2018 14:04

TOP NEWS: Shire Launches Tender Offer To Buy Up To USD2 Billion Notes (ALLISS)

LONDON (Alliance News) - Biotechnology company Shire PLC on Friday said its wholly-owned subsidiaries Baxalta and Shire Acquisitions Investments Ireland DAC launched a tender offer to repurchase a

Read more
24 Aug 2018 13:54

MARKET ANALYSIS: Futures Pointing To Initial Strength On Wall Street

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Friday, with stocks likely to move to the upside after ending the previous session modestly upward on a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.